Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic Melanoma

NCT01005537 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: therapeutic autologous lymphocytes
DRUG: cyclophosphamide

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]